AXIOS January 4, 2023
Oriana Gonzalez

The Food and Drug Administration yesterday added a new twist to the escalating fight over medication abortion by allowing pharmacies to offer the pills — even as anti-abortion groups mount a unique legal challenge to the approved use of the drugs.

The big picture: The developments underscore how much access to mifepristone, which is used in first-trimester abortions, has become a focal point in the reproductive health wars since the Supreme Court struck down precedents that established a federal right to abortion.

  • Medication abortion accounts for over half of abortions in the country. Abortion pills are frequently prescribed online and mailed to patients, effectively providing a way to circumvent state restrictions that took effect after the high court decision...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Pharma, Pharma / Biotech, Provider
Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know

Share This Article